Mg Biological Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
- Revenue Growth %
- Profit Growth 2484.58%
- Ebitda 4059.41%
- Net Worth 369.00%
- Total Assets 1798.41%
About Mg Biological
Mg Biological Private Limited (MBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 November 2021 (Three years and three months 7 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.50 Cr.
Varun Kumar, Fayazul Islam, and Mohd Akhalaque serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85190DL2021PTC389496
-
Company No.
389496
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Nov 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Mg Biological?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Varun Kumar
|
Director | 08-Nov-2021 | Current |
|
Fayazul Islam
|
Director | 08-Nov-2021 | Current |
|
Mohd Akhalaque
|
Director | 08-Nov-2021 | Current |
Financial Performance of Mg Biological.
Mg Biological Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 2484.58% increase in profit. The company's net worth Soared by an impressive increase of 369%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mg Biological?
Unlock access to Mg Biological's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Corelex Solutions Private LimitedFayazul Islam is a mutual person
-
Danube Overseas Consultancy Services Private Limited
Fayazul Islam is a mutual person
Charges (Loans)
₹15.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Aug 2023 | Others | ₹1.50 Cr | Open |
How Many Employees Work at Mg Biological?
Mg Biological has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mg Biological, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mg Biological's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.